1Boumpas DT,Austin HA,Vaughn EM,et al.Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.Lancet,1992,340:741-745.
2Gourley MF,Austin HA,Scott D,et al.Methylprednisolone and cyclophosphamide,alone or in combination,in patients with lupus nephritis.Ann Intern Med,1996,125:549-557.
3Illei GG,Austin HA,Crane M,et al.Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.Ann Intern Med,2001,135:248-257.
4Austin HA,Klippel JH,Balow JE,et al.Therapy of lupus nephritis:controlled trial of prednisolone and cytotoxic drugs.New Engl J Med,1986,314:614-619.
5Gorman C,Bhatia A,Rahman A.This house believes that lowdose intravenous cyclophosphamide is superior to standard highdose regimens for treatment of lupus nephritis.Rheumatology,2005,44:398-401.
6Houssiau FA,Vasconcelos C,D'Cruz D,et al.Immunosuppressive therapy in lupus nephritis.Arthritis Rheum,2002,46:2121-2131.
7Martin-Suarez I,D'Cruz D,Mansoor M,et al.Immunosuppressive treatment in severe connective tissue diseases:effects of low dose intravenous cyclophosphamide.Ann Rheum Dis,1997,56:481-487.
